![]() Tessera’s gene writing technology is designed to “write therapeutic instructions” into the genome in order to treat a disease at its source. I am honored to help move this vision forward.” “By harnessing the power of mobile genetic elements, Tessera’s Gene Writing platform is poised to realize the full potential of genetic medicine and make an unprecedented impact on human health. I am excited to join the team at Tessera Therapeutics to bring innovative gene writing therapies into the clinic,” Davidson said in a statement. “I have been privileged to lead the clinical development of gene therapy programs from inception through approval to deliver these transformative medicines to patients with life-threatening diseases. Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large. Prior to his tenure at bluebird, Davidson led clinical research for a wide range of therapeutic programs at Genzyme and GelTex, spanning biologics, polymers and gene therapy. SOMERVILLE, Mass., Ap(GLOBE NEWSWIRE) - Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing, announced the. ”Together and alongside our current senior leadership team, they will be instrumental in advancing Tessera’s mission to bring forth innovative and curative medicines that go beyond the limitations of current technologies,” von Maltzahn said in a statement. a cofounder of Intellia Therapeutics and a Scientific Advisory Board member at Tessera Therapeutics. Geoffrey von Maltzahn, founder and chief executive officer of Tessera Therapeutics, said Davidson, Pujar and Guey “bring a wealth of strategic leadership and deep expertise” to the company. Davidson is one of several executives who have departed bluebird in recent months. a new company with the mission of curing disease by writing in the code of life. Sickle cell disease treatment and looking to split into two entities. Flagship Pioneering today announced the unveiling of Tessera Therapeutics, Inc. ![]()
0 Comments
Leave a Reply. |